Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

48 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition.
Nilsson M, Carlsson A, Markinhuhta KR, Sonesson C, Pettersson F, Gullme M, Carlsson ML. Nilsson M, et al. Among authors: sonesson c. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jul;28(4):677-85. doi: 10.1016/j.pnpbp.2004.05.004. Prog Neuropsychopharmacol Biol Psychiatry. 2004. PMID: 15276693
In vivo pharmacology of the dopaminergic stabilizer pridopidine.
Ponten H, Kullingsjö J, Lagerkvist S, Martin P, Pettersson F, Sonesson C, Waters S, Waters N. Ponten H, et al. Among authors: sonesson c. Eur J Pharmacol. 2010 Oct 10;644(1-3):88-95. doi: 10.1016/j.ejphar.2010.07.023. Epub 2010 Jul 24. Eur J Pharmacol. 2010. PMID: 20667452 Free article.
Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease.
Waters S, Sonesson C, Svensson P, Tedroff J, Carta M, Ljung E, Gunnergren J, Edling M, Svanberg B, Fagerberg A, Kullingsjö J, Hjorth S, Waters N. Waters S, et al. Among authors: sonesson c. J Pharmacol Exp Ther. 2020 Jul;374(1):113-125. doi: 10.1124/jpet.119.264226. Epub 2020 May 1. J Pharmacol Exp Ther. 2020. PMID: 32358046
Synthesis of [11C-methyl]-(-)-OSU6162, its regional brain distribution and some pharmacological effects of (-)-OSU6162 on the dopaminergic system studied in the rhesus monkey by positron emission tomography.
Neu H, Hartvig P, Torstenson R, Fasth KJ, Sonesson C, Waters N, Carlsson A, Tedroff J, Långström B. Neu H, et al. Among authors: sonesson c. Nucl Med Biol. 1997 Aug;24(6):507-11. doi: 10.1016/s0969-8051(97)00023-1. Nucl Med Biol. 1997. PMID: 9316077
(3S)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine (IRL752) -a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent.
Hjorth S, Waters S, Waters N, Tedroff J, Svensson P, Fagerberg A, Edling M, Svanberg B, Ljung E, Gunnergren J, McLean SL, Grayson B, Idris NF, Neill JC, Sonesson C. Hjorth S, et al. Among authors: sonesson c. J Pharmacol Exp Ther. 2020 Sep;374(3):404-419. doi: 10.1124/jpet.120.000037. Epub 2020 Jun 30. J Pharmacol Exp Ther. 2020. PMID: 32605972
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia.
Svenningsson P, Odin P, Dizdar N, Johansson A, Grigoriou S, Tsitsi P, Wictorin K, Bergquist F, Nyholm D, Rinne J, Hansson F, Sonesson C, Tedroff J; IRL752 Collaborators. Svenningsson P, et al. Among authors: sonesson c. Mov Disord. 2020 Jun;35(6):1046-1054. doi: 10.1002/mds.28020. Epub 2020 Mar 21. Mov Disord. 2020. PMID: 32198802 Clinical Trial.
Self-administered measurement of symphysis-fundus heights.
Bergman E, Kieler H, Petzold M, Sonesson C, Axelsson O. Bergman E, et al. Among authors: sonesson c. Acta Obstet Gynecol Scand. 2007;86(6):671-7. doi: 10.1080/00016340701258867. Acta Obstet Gynecol Scand. 2007. PMID: 17520397 Free article.
Are flexible designs sound?
Burman CF, Sonesson C. Burman CF, et al. Among authors: sonesson c. Biometrics. 2006 Sep;62(3):664-9; discussion 670-83. doi: 10.1111/j.1541-0420.2006.00626.x. Biometrics. 2006. PMID: 16984302